Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
12%
OVERLAP
BY WEIGHT
3
# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
11%
ALSO IN PSIL
PSIL
32
HOLDINGS
25%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus PSIL)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in PSIL |
Overlap | |
|---|---|---|---|---|
| ALKERMES PLC | 4.4% | 4.0% | 4.0% | |
| ABBVIE INC | 8.2% | 3.9% | 3.9% | |
| JOHNSON & JOHNSON | 5.5% | 3.7% | 3.7% | |
MEDX Overweight Relative to PSIL
| ELI LILLY & CO | 17.1% | |
| NOVARTIS AG-ADR | 7.2% | |
| ASTRAZENECA PLC | 5.4% | |
| BRISTOL-MYERS SQUIBB CO | 4.8% | |
| IONIS PHARMACEUTICALS, INC. | 4.7% | |
| ABBVIE INC | 4.3% | |
| AMGEN INC | 3.9% | |
| MERCK & CO. INC. | 3.8% | |
| ALNYLAM PHARMACEUTICALS INC | 3.6% | |
| PFIZER INC | 3.3% |
MEDX Underweight Relative to PSIL
| RELMADA THERAPEUTICS INC | -9.3% | |
| DEFINIUM THERAPEUTICS INC | -8.7% | |
| NEURONETICS, INC. | -5.7% | |
| BRIGHT MINDS BIO | -5.1% | |
| ALTO NEUROSCIENCE INC | -4.7% | |
| NEUROCRINE BIOSCIENCES INC | -4.4% | |
| SUPERNUS PHARMACEUTICALS INC | -3.6% | |
| NUMINUS WELLNESS INC | -0.9% | |
| INDIA GLOBALIZATION CAPITAL, INC. | -0.5% | |
| PACIFIC BIOSCIENCES OF CALIF | 0.1% |